DL-Alanine benzyl ester 4-toluenesulfonate salt
Need Assistance?
  • US & Canada:
    +
  • UK: +

DL-Alanine benzyl ester 4-toluenesulfonate salt

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
DL-Amino Acids
Catalog number
BAT-003613
CAS number
46229-47-4
Molecular Formula
C10H13NO2·C7H8SO3
Molecular Weight
351.40
DL-Alanine benzyl ester 4-toluenesulfonate salt
IUPAC Name
benzyl 2-aminopropanoate;4-methylbenzenesulfonic acid
Synonyms
DL-Ala-OBzl TosOH; Benzyl 2-aminopropanoate 4-methylbenzenesulfonate
Related CAS
5557-81-3 (hydrochloride)
Appearance
White to off-white powder
Purity
≥ 98% (assay)
Melting Point
78-87 °C
Storage
Store at 2-8°C
InChI
InChI=1S/C10H13NO2.C7H8O3S/c1-8(11)10(12)13-7-9-5-3-2-4-6-9;1-6-2-4-7(5-3-6)11(8,9)10/h2-6,8H,7,11H2,1H3;2-5H,1H3,(H,8,9,10)
InChI Key
NWOPHJSSBMABBD-UHFFFAOYSA-N
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC(C(=O)OCC1=CC=CC=C1)N

DL-Alanine benzyl ester 4-toluenesulfonate salt, a versatile compound with diverse applications in bioscience, is utilized across various fields. Here are the key applications presented with high perplexity and burstiness:

Pharmaceutical Synthesis: Positioned as a pivotal intermediate in pharmaceutical synthesis, DL-Alanine benzyl ester 4-toluenesulfonate salt contributes significantly to the creation of novel drug compounds. By integrating this compound into intricate chemical reactions, researchers can craft drug molecules with heightened efficacy and reduced side effects, pushing the boundaries of medicinal chemistry towards the development of novel therapeutic agents.

Peptide Synthesis: Within the realm of peptide synthesis, DL-Alanine benzyl ester 4-toluenesulfonate salt emerges as a crucial protected amino acid derivative. This essential role involves safeguarding functional groups during peptide bond formation, ensuring the precision and effectiveness of synthesis processes. An indispensable component for generating therapeutic peptides, peptide-based materials, and bioconjugates, this compound plays a vital role in advancing medical research.

Biomaterials: Pioneering the fabrication of biomaterials for medical use, including drug delivery systems and tissue engineering scaffolds, DL-Alanine benzyl ester 4-toluenesulfonate salt enhances mechanical properties and biocompatibility. By incorporating this compound, biomaterials achieve enhanced functionality, rendering them suitable for a myriad of biomedical applications such as wound healing and regenerative medicine. This innovation propels the boundaries of biomaterial research towards transformative medical solutions.

Enzyme Studies: In biochemical inquiries, DL-Alanine benzyl ester 4-toluenesulfonate salt serves as a crucial substrate for enzymatic assays, enabling a deeper dive into enzyme kinetics and specificity. By monitoring enzymatic cleavage processes involving this compound, researchers unlock insights into enzyme mechanisms and activity levels. These studies play a vital role in unraveling metabolic pathways, fostering a deeper understanding of enzyme behavior, and aiding in the development of targeted enzyme inhibitors for therapeutic interventions.

1.Nickel-catalyzed reductive methylation of alkyl halides and acid chlorides with methyl p-tosylate.
Liang Z1, Xue W, Lin K, Gong H. Org Lett. 2014 Nov 7;16(21):5620-3. doi: 10.1021/ol502682q. Epub 2014 Oct 21.
Methylation of unactivated alkyl halides and acid chlorides under Ni-catalyzed reductive coupling conditions led to efficient formation of methylated alkanes and ketones using methyl p-methyl tosylate as the methylation reagent. Moderate to excellent coupling yields as well as excellent functional group tolerance were observed under the present mild and easy-to-operate reaction conditions.
2.Photodynamic inactivation of Candida albicans sensitized by tri- and tetra-cationic porphyrin derivatives.
Cormick MP1, Alvarez MG, Rovera M, Durantini EN. Eur J Med Chem. 2009 Apr;44(4):1592-9. doi: 10.1016/j.ejmech.2008.07.026. Epub 2008 Jul 26.
The photodynamic action of 5-(4-trifluorophenyl)-10,15,20-tris(4-trimethylammoniumphenyl)porphyrin iodide (TFAP(3+)) and 5,10,15,20-tetra(4-N,N,N-trimethylammonium phenyl)porphyrin p-tosylate (TMAP(4+)) has been studied in vitro on Candida albicans. The results of these cationic porphyrins were compared with those of 5,10,15,20-tetra(4-sulphonatophenyl)porphyrin (TPPS(4-)), which characterizes an anionic sensitizer. In vitro investigations show that these cationic porphyrins are rapidly bound to C. albicans cells, reaching a value of approximately 1.4 nmol/10(6) cells, when the cellular suspensions were incubated with 5 microM sensitizer for 30 min. In contrast, TPPS(4-) is poorly uptaken by yeast cells. The fluorescence spectra of these sensitizers into the cells confirm this behaviour. The amount of porphyrin binds to cells is dependent on both sensitizer concentrations (1-5 microM) and cells densities (10(6)-10(8) cells/mL). Photosensitized inactivation of C.
3.A nonionic porphyrin as a noninterfering DNA antibacterial agent.
Mendes S1, Camacho F, Silva T, Calado CR, Serra AC, Gonsalves AM, Roxo-Rosa M. Photochem Photobiol. 2011 Nov-Dec;87(6):1395-404. doi: 10.1111/j.1751-1097.2011.00984.x. Epub 2011 Sep 14.
The increasing interest in clinical bacterial photodynamic inactivation has led to the search for photosensitizers with higher bactericidal efficiency and less side effects on the surrounding tissues. We present a novel nonionic porphyrin, the 5,10,15-tris(2,6-dichlorophenyl)-20-[4-N-(6-amino-hexyl)sulfonamido)phenyl]-porphyrin (ACS769F4) with substantial improvements in the efficiency of nonionic sensitizers. This porphyrin causes eradication of both Escherichia coli and Staphylococcus aureus by the photodynamic effect but in higher concentrations compared with 5,10,15,20-tetrakis (4-N,N,N-trimethylammoniumphenyl)-porphyrin p-tosylate (TTAP(4+)), a known bactericidal tetracationic porphyrin. More important, under such conditions, ACS769F4 proved to be harmless to two mammalian cells lines (human embryonic and baby hamster kidney), causing no reduction in their viability or negative impact on their cytoskeleton, despite its accumulation in cellular structures.
4.Morphology modification of silver microstructures fabricated by multiphoton photoreduction.
Jin W1, Zheng ML, Cao YY, Dong XZ, Zhao ZS, Duan XM. J Nanosci Nanotechnol. 2011 Oct;11(10):8556-60.
We have investigated the morphology modification of silver microstructures fabricated by the multiphoton photoreduction process. The microstructures have been fabricated by a femtosecond laser under different irradiation time and repeated scanning numbers. Trans-4-[4-(dimethylamino)-N-methylstilbazolium] p-tosylate (DAST) was used as photosensitizer and effectively reduced the laser power to 0.66 mW. The increase of the irradiation time and repeated scanning induced more reduction in the multiphoton photoreduction microfabrication process, resulting in the optimization of the linewidth. The fusion of silver nanoparticles was confirmed, which led to the morphology change of silver microstructures for achieving the compact metallic microstructures. The result would provide an important protocol to fabricate the metallic microstructures for the electronic and photonic applications.
Online Inquiry
Verification code
Inquiry Basket